Cevimeline (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Cevimeline drug offered from Ranbaxy Pharmaceuticals Inc.. This Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Cevimeline |
| SUBSTANCE NAME: | CEVIMELINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-03-10 |
| END MARKETING DATE: | 0000-00-00 |
Cevimeline HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cevimeline from Ranbaxy Pharmaceuticals Inc. |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/1) |
| START MARKETING DATE: | 2016-03-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-479_162060fe-7706-43f3-a1d9-7ccc5befcf5f |
| PRODUCT NDC: | 63304-479 |
| APPLICATION NUMBER: | NDA020989 |
Other CEVIMELINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
